• Apr 28, 2025

3 Market-Beating Stocks with Solid Fundamentals

Stocks that outperform the market usually share key traits such as rising sales, expanding margins, and increasing returns on capital. The select few that can do all three for many years are often the ones that make you life-changing money.

  • Apr 28, 2025

1 of Wall Street’s Favorite Stock with Impressive Fundamentals and 2 to Ignore

The stocks in this article have caught Wall Street’s attention in a big way, with price targets implying returns above 20%. But investors should take these forecasts with a grain of salt because analysts typically say nice things about companies so their firms can win business in other product lines like M&A advisory.

  • Apr 28, 2025

1 of Wall Street’s Favorite Stock for Long-Term Investors and 2 to Be Wary Of

The stocks in this article have caught Wall Street’s attention in a big way, with price targets implying returns above 20%. But investors should take these forecasts with a grain of salt because analysts typically say nice things about companies so their firms can win business in other product lines like M&A advisory.

  • Apr 28, 2025

2 of Wall Street’s Favorite Stocks Worth Investigating and 1 to Brush Off

Wall Street is overwhelmingly bullish on the stocks in this article, with price targets suggesting significant upside potential. However, it’s worth remembering that analysts rarely issue sell ratings, partly because their firms often seek other business from the same companies they cover.

  • Apr 28, 2025

3 Value Stocks That Concern Us

Value stocks typically trade at discounts to the broader market, offering patient investors the opportunity to buy businesses when they’re out of favor. The key risk, however, is that these stocks are usually cheap for a reason – five cents for a piece of fruit may seem like a great deal until you find out it’s rotten.

  • Apr 28, 2025

3 Healthcare Stocks That Concern Us

From novel pharmaceuticals to telemedicine, most healthcare companies are on a mission to drive better patient outcomes. Despite the rosy long-term prospects, short-term headwinds such as COVID inventory destocking have harmed the industry’s returns - over the past six months, healthcare stocks have collectively shed 11.7%. This drawdown was worse than the S&P 500’s 5.2% decline.

  • Apr 28, 2025

2 Hated Stocks that Deserve a Second Chance and 1 to Think Twice About

Wall Street has issued downbeat forecasts for the stocks in this article. These predictions are rare - financial institutions typically hesitate to say bad things about a company because it can jeopardize their other revenue-generating business lines like M&A advisory.